p82 Where the report outlines the disconnect:
”Procedures of limited clinical value: our evidence and our concerns
Taken as a whole, the data related to breast surgery procedures deemed to be of limited clinical value raises significant concerns:
- that across the country as a whole, it is becoming harder for individuals to access aesthetic breast surgery despite having a recognised medical condition; and
- that there is considerable national variation in access to aesthetic breast surgery for a medical condition.
We disagree with the assertion that these operations are of limited clinical value. Surgery for a congenital condition can make an immense difference to a young woman’s, or young man’s, confidence and quality of life. Clearly, there need to be gateways and caveats to such surgery, but at present, it appears that the barriers to receiving surgery are greater in some areas than in others.
In this context, it is striking to note how NHS Specialised Commissioning has facilitated greater access to gender reassignment surgery for gender dysphoria – even though some of the surgical procedures involved are the same as those used to treat e.g. congenital breast developmental issues.
We see it as both inconsistent and illogical that a procedure can be deemed of limited clinical value for one group of patients or medical condition, but acceptable for another, where there is no substantial difference in the surgical outcomes.
Clear criteria exist for commissioning breast reduction surgery – as set out in the 2018 Evidence-Based Interventions: Guidance for Clinical Commissioning Groups (CCGs).85 However, it is apparent from our visits that these guidelines are not uniformly being adhered to.
Clear, evidence-based guidelines should be applied consistently and fairly to all individuals seeking surgery for congenital, developmental and acquired anomalies across the country.”
If you’re wondering about the difference between cosmetic breast surgery and aesthetic breast surgery, as well as what is meant by “low clinical value” here is the definition from p74
”The difference between cosmetic and aesthetic breast surgery
Cosmetic breast surgery can be defined as when surgical procedures are used to alter the breast appearance for personal preference. However, if these same procedures are required to support recovery from or reduce the risk of breast cancer, or indicated for a recognised medical problem such as gender dysphoria, failure of breast development, or overgrowth of the male breast because of cancer treatments, they are better termed aesthetic breast surgery procedures.
This is a subtle but important distinction: cosmetic breast procedures cannot and should not be routinely funded by the NHS, but breast surgery procedures for aesthetic purposes can and should be. At an individual patient level, the value of aesthetic breast surgery to correct a medical condition is often considerable, particularly in terms of the patient’s overall psychological wellbeing and quality of life. This is demonstrated by the fact that corrective aesthetic breast surgery has been clearly acknowledged as essential to facilitate high-quality recovery and survivorship after breast cancer surgery.
However, for other equally well-recognised medical conditions, the use of the same or similar breast surgery techniques for corrective aesthetic purposes are commonly banded under the umbrella term ‘procedures of low clinical value’ (PoLCV).77 This means access to corrective aesthetic surgery for these other medical conditions is dependent on local CCG policies and guidelines. With budgets stretched, such procedures can then appear as easy targets to be cut or severely restricted.”
This all goes back to underfunding of the NHS imho. With not enough money for all aesthetic breast surgery which should be funded, patients are being denied surgery when they shouldn’t be. And of course, any priority system you apply to fix the problem of too many patients and not enough money will rightly or wrongly prioritise one condition over another. The NHS CCGs may be getting their priorities wrong, but they wouldn’t have to prioritise anyone and turn away anyone if the NHS were adequately funded for the aesthetic breast surgery need.